Platelet-covered nanocarriers for targeted delivery of hirudin to eliminate thrombotic complication in tumor therapy
Most patients are at high risk of thrombosis during cancer treatment. However, the major discrepancy in the therapeutic mechanisms and microenvironment between tumors and thrombosis makes it challenging for a panacea to treat cancer while being able to eliminate the risk of thrombosis. Herein, we de...
| المؤلفون الرئيسيون: | , , , , , , |
|---|---|
| مؤلفون آخرون: | |
| التنسيق: | Journal Article |
| اللغة: | English |
| منشور في: |
2023
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://hdl.handle.net/10356/170511 |